. "The new money will be invested in four main areas: * operational infrastructure and facilities; * marketing and sales capacity, including further development of the company's US organisation; * capital equipment; and * R&D. Part of the manufacturing expenditure will be devoted to the development of patented continuous plasma-processing systems supporting higher-volume applications of P2i's technol" . . .